Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anushka K Palipana

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chest|January 7, 2023
Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With LymphangioleiomyomatosisAnushka K Palipana, Emrah Gecili, Seongho Song, et al.
Statistics in Medicine|April 25, 2025
A Joint Model for (Un)Bounded Longitudinal Markers, Competing Risks, and Recurrent Events Using Patient Registry DataPedro Miranda Afonso, Dimitris Rizopoulos, Anushka K Palipana, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 23, 2026
Comparing Patient-level Social Drivers of Health from Health Surveys and Electronic Health Records for Patients with Comorbid Hypertension and Uncontrolled DiabetesSomin Sang, Susan G Silva, Susan E Spratt, et al.
Respiratory Research|April 27, 2024
Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapyGrace C Zhou, Ziyun Wang, Anushka K Palipana, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 10, 2025
Real-world association between ivacaftor initiation and lung function variability: A registry studyRhonda D Szczesniak, Eleni-Rosalina Andrinopoulou, Hancheng Li, et al.
Plos One|July 18, 2024
A study protocol for risk stratification in children with concussion (RSiCC): Theoretical framework, design, and methodsKarin Reuter-Rice, Amanda N Fitterer, Peter Duquette, et al.
Environmental Advances|December 14, 2023
Social-environmental phenotypes of rapid cystic fibrosis lung disease progression in adolescents and young adults living in the United StatesAnushka K Palipana, Andrew Vancil, Emrah Gecili, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chest|January 7, 2023
Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With LymphangioleiomyomatosisAnushka K Palipana, Emrah Gecili, Seongho Song, et al.
Statistics in Medicine|April 25, 2025
A Joint Model for (Un)Bounded Longitudinal Markers, Competing Risks, and Recurrent Events Using Patient Registry DataPedro Miranda Afonso, Dimitris Rizopoulos, Anushka K Palipana, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 23, 2026
Comparing Patient-level Social Drivers of Health from Health Surveys and Electronic Health Records for Patients with Comorbid Hypertension and Uncontrolled DiabetesSomin Sang, Susan G Silva, Susan E Spratt, et al.
Respiratory Research|April 27, 2024
Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapyGrace C Zhou, Ziyun Wang, Anushka K Palipana, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 10, 2025
Real-world association between ivacaftor initiation and lung function variability: A registry studyRhonda D Szczesniak, Eleni-Rosalina Andrinopoulou, Hancheng Li, et al.
Plos One|July 18, 2024
A study protocol for risk stratification in children with concussion (RSiCC): Theoretical framework, design, and methodsKarin Reuter-Rice, Amanda N Fitterer, Peter Duquette, et al.
Environmental Advances|December 14, 2023
Social-environmental phenotypes of rapid cystic fibrosis lung disease progression in adolescents and young adults living in the United StatesAnushka K Palipana, Andrew Vancil, Emrah Gecili, et al.
Pageof 1